PedAM
Pediatric Disease Annotations & Medicines
| Disease | tuberculosis |
| Phenotype | C0033860|psoriasis |
| Sentences | 18 |
| PubMedID- 23786208 | Isoniazid therapy for latent tuberculosis in psoriasis patients receiving biological agents: is it safe and efficacious. |
| PubMedID- 25753908 | The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents. |
| PubMedID- 21054332 | Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor-alpha treatment: every new solution breeds new doubts. |
| PubMedID- 21083541 | Within the asia-pacific region, the tuberculosis risk in patients with psoriasis who use tumour necrosis factor (tnf) blockers is unknown. |
| PubMedID- 19609541 | However, it is not known whether the chronically activated immune system of psoriasis patients interferes with their mycobacterium tuberculosis (mtb)-specific immunity, especially in tuberculosis-endemic areas like brazil. |
| PubMedID- 24863903 | Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy. |
| PubMedID- 23909256 | Interferon-gamma release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis. |
| PubMedID- 21629971 | Evaluation of an ifn-gamma assay in the diagnosis of latent tuberculosis in patients with psoriasis in a highly endemic setting. |
| PubMedID- 23094309 | Severe psoriasis with positive tuberculosis test and treatment with biologic therapy: a case report. |
| PubMedID- 26508833 | In the people's republic of china, an intermediate tuberculosis-burden country, the latent tuberculosis infection (ltbi) risk in patients with psoriasis who are treated with etanercept, the safest kind of tnf-alpha blocker, is unknown. |
| PubMedID- 21987138 | Investigation of latent tuberculosis infection in patients with psoriasis who are candidate for receiving immunobiological drugs. |
| PubMedID- 23134268 | Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in spain. |
| PubMedID- 25612132 | Pulmonary sarcoidosis and latent tuberculosis in a patient with psoriasis treated with adalimumab. |
| PubMedID- 22529801 | Moreover, in one study the in vitro t cell responsiveness was diminished towards mycobacterium tuberculosis in cases with severe psoriasis [4]. |
| PubMedID- 25120233 | Latent tuberculosis reactivation in a patient with erythrodermic psoriasis under treatment with ustekinumab and a low dose steroid, despite isoniazid chemoprophylaxis. |
| PubMedID- 23375515 | Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from taiwan. |
| PubMedID- 22206087 | Improvement in psoriasis after treatment of reactivated latent tuberculosis following initiation of tnf-alpha inhibitor therapy has yet to be described in the literature. |
| PubMedID- 23278714 | Evaluating the use of the interferon-gamma response to mycobacterium tuberculosis-specific antigens in patients with psoriasis prior to antitumour necrosis factor-alpha therapy: a prospective head-to-head cross-sectional study. |
Page: 1